Since 1968, scientists have explored the enzymatic process in magic mushrooms that produces its active chemical, psilocybin. Not until a brand new study—published in the German journal Angewandte Chemie—has it been decoded. Scientists sequenced the genomes of two magic mushroom species, Psilocybe cubensis and Psilocybe cyanescens. Through enzyme isolation and splicing, they were later able to create their own psilocybin—something that could ultimately be beneficial for the pharmaceutical world. Yes, the process is complex but this new information can help develop a psychedelic fungal drug production process. Read more at Gizmodo.